Lihui Zou is the founder of Degron Therapeutics. Degron Therapeutics has raised $22M in total funding. Latest round: Series A.
Lihui Zou, referred to as Lily Zou, Ph.D., is the co-founder and CEO of Degron Therapeutics. The company, founded in 2021, focuses on developing a new class of small-molecule medicines using its proprietary GlueXplorer platform. She leads a team of entrepreneurs, scientists, and clinicians to advance novel drugs for previously undruggable targets.
Full founder directory · Investor directory · Company funding database · Fundraising library